Phase 2a, randomized, double-blind, placebo-controlled dose-ranging study of repeat doses of collagenase clostridium histolyticum for the treatment of edematous fibrosclerotic panniculopathy (cellulite)
2015 ◽
Vol 72
(5)
◽
pp. AB19
◽
2016 ◽
Vol 41
(9)
◽
pp. S31
◽
2008 ◽
Vol 7
(9)
◽
pp. 796-804
◽
Keyword(s):
2015 ◽
Vol 14
(2)
◽
pp. e134
◽
2017 ◽
Vol 31
(9)
◽
pp. 1190-1203
◽
2014 ◽
Vol 109
◽
pp. S541
◽
Keyword(s):